Biomarin Pharmaceutical Aktie
50,78
EUR
-0,96
EUR
-1,86
%
59,08
USD
-1,26
USD
-2,09
%
Werbung
Biomarin Pharmaceutical Aktie Analyse
| 19.07.05 | Biomarin Pharmaceutical | Global Biotech Investing | |
| 12.05.05 | Biomarin Pharmaceutical Market Outperform | Rodman & Renshaw |
Werbung
Werbung